AstraZeneca (LON:AZN)‘s stock had its “neutral” rating reaffirmed by JPMorgan Chase & Co. in a research note issued on Friday, AnalystRatings.NET reports. AZN has been the subject of a number of other recent research reports. Analysts at Jefferies Group reiterated an “underperform” rating on shares of AstraZeneca in a research note to investors on Friday. […]
AstraZeneca Stock Rating Reaffirmed by JPMorgan Chase & Co. (AZN) is a post from: Zolmax
The post AstraZeneca Stock Rating Reaffirmed by JPMorgan Chase & Co. (AZN) appeared first on Zolmax.